Host: Rabbit
Target Protein: IL-17
Immunogen Range: 35-130/155
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 3605
Swiss Prot: Q16552
Source: KLH conjugated synthetic peptide derived from human IL-17
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
Predicted Molecular Weight: 15
Cross Reactive Species: Human
For research use only. Not intended for diagnostic or therapeutic use.
- Niu, Yinghua, et al. "The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease." BMC immunology 12.1 (2011): 47.Read more>>
- Kou, Wei, et al. "Transforming growth factor-??1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment."Inflammation Research (2013): 1-7.2Read more>>
- Ghazi, H. F., N. A. Mohammed, and R. J. Hussein. "Tissue IL-17A expression associated with inflammatory lesions and ATG16L1 T300A allele in Crohn’s disease." International Journal of Advanced Research 3.1 (2015): 33-40.Read more>>
- Tang, Wei‑Jing, et al. "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." Oncology Letters.Read more>>
- Tang et al. Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. (2017) Oncol.Lett. 14:561-568Read more>>
- Mangino G et al. Interleukin‐17A affects extracellular vesicles release and cargo in human keratinocytes. Exp Dermatol. 2019 Sep;28(9):1066-1073. Read more>>
- Haghighi Javid Asal. et al. IL-17A immune pattern across genetic acantholytic and blistering disorders. CLIN EXP DERMATOL. 2023 JaRead more>>
- Ettinger Monika. et al. Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets. NAT COMMUN. 2023 Nov;14(1):1-1Read more>>
Formalin-fixed and paraffin embedded human oral squamous cell carcinoma labeled with Anti-IL-17 Polyclonal Antibody, Unconjugated(bs-2140R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Lane 1: MOLT-4 cell lysates; Lane 2: U937 cell lysates probed with IL17 Polyclonal Antibody, Unconjugated (bs-2140R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Raji cell lysates probed with IL17 Polyclonal Antibody, Unconjugated (bs-2140R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: MCF-7 cell lysates probed with IL-17 Polyclonal Antibody, Unconjugated (bs-2140R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.